Malte Peters serves as Executive at Tango Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Malte Peters has executed 7 insider transactions totaling $47.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 8, 2026 involved receiving (via award) 1,650,000 shares valued at $0.
Malte Peters currently holds 1,650,000 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Malte Peters has been a net seller of TNGX stock. They have purchased $0 and sold $47.5K worth of shares.
Malte Peters's most recent insider trade was on Jan 8, 2026, when they sold 1,650,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 19, 2025 | HOOK | $20.6K | Sale | 25,172 | $0.82 | Discretionary |
| Jul 22, 2025 | HOOK | $26.8K | Sale | 29,176 | $0.92 | Discretionary |
| Jul 22, 2024 | HOOK | $0 | Award | 108,695 | $N/A | Discretionary |
| Jun 5, 2024 | TNGX | $0 | Award | 6,250 | $N/A | Discretionary |
| Jun 6, 2023 | TNGX | $0 | Award | 5,000 | $N/A | Discretionary |